The foramen ovale is a part of normal fetal anatomy that typically closes early in life. The foramen ovale remains patent in approximately a quarter of the population. Patent foramen ovale has an increased incidence among individuals with migraine headache and cryptogenic stroke. Percutaneous closure of patent foramen ovale (PFO) is a secondary prevention measure for individuals with PFO and migraine headache or cryptogenic stroke. Results from randomized controlled trials are awaited in order to determine the safety and efficacy of percutaneous PFO closure in the treatment of migraine headache and cryptogenic stroke in comparison to the currently recommended standards of medical care. This article provides the advanced practice nurse a review of PFO anatomy and diagnostics, a review of the current science regarding percutaneous PFO closure as a treatment for stroke and migraine headache, as well as implications for nursing practice. Nurse practitioners should be advocates for their patients by coordinating with neurologists and cardiologists to ensure patients receive the most appropriate care.
Metrics
1 File views/ downloads
23 Record Views
Details
Title
Incidence of Patent Foramen Ovale in Adults with Cryptogenic Stroke or Migraine Headache
Creators
Megan M. Streur
Contributors
Renee Hoeksel (Advisor)
Awarding Institution
Washington State University
Academic Unit
Research Projects, College of Nursing
Theses and Dissertations
Master of Nursing (MN), Washington State University
Publisher
Washington State University; Spokane, Washington
Identifiers
99900590737801842
Copyright
http://creativecommons.org/licenses/by-nc-sa/3.0/us; Creative Commons Attribution-NonCommercial-ShareAlike 3.0 United States (CC BY-NC-SA 3.0 US)